Has Keren Yizhak uncovered the fountain of youth? This doctoral student at Tel Aviv University in Israel has developed a powerful bioinformatics approach to combat aging. Her study, published in Nature Communications, paves the way for new drugs targeting aging and its effects.
Editing Cells with Precision
Bioinformatics leverages algorithms to selectively eliminate or reprogram cells. Much of this research focuses on destroying cancer cells or pathogens. Yizhak's team created a "metabolic transformation algorithm" that pinpointed two key genes—GREB1 and ADH2—profoundly impacting lifespan.
Medications on the Horizon?
No human trials have occurred yet, so efficacy in people remains unproven. However, ongoing experiments are rejuvenating aged cells. In time, this could yield drugs extending human lifespan and mitigating aging signs. Beyond longevity, the algorithm holds promise for tackling diabetes, obesity, neurodegenerative diseases, and select cancers.
